标题
Novel Antiatherosclerotic Therapies
作者
关键词
-
出版物
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Volume 39, Issue 4, Pages 538-545
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2019-02-28
DOI
10.1161/atvbaha.118.310958
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Moving Targets
- (2019) Lars E. Larsen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- New Insights from Studies of Clonal Hematopoiesis
- (2018) Christopher J. Gibson et al. CLINICAL CANCER RESEARCH
- OUP accepted manuscript
- (2018) EUROPEAN HEART JOURNAL
- Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
- (2018) Paul M Ridker et al. LANCET
- Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms
- (2018) Ofir Wolach et al. Science Translational Medicine
- Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome
- (2018) Kaivan Vaidya et al. JACC-Cardiovascular Imaging
- Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions
- (2018) Paolo Raggi et al. ATHEROSCLEROSIS
- Targeting the NLRP3 inflammasome in inflammatory diseases
- (2018) Matthew S. J. Mangan et al. NATURE REVIEWS DRUG DISCOVERY
- Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
- (2018) Aruna D. Pradhan et al. AMERICAN HEART JOURNAL
- Medical Therapy for Long-Term Prevention of Atherothrombosis Following an Acute Coronary Syndrome
- (2018) Guglielmo Gallone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk
- (2018) Paul M Ridker JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease
- (2018) JoAnn E. Manson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure
- (2018) Lena Dorsheimer et al. JAMA Cardiology
- Epigenetics and precision medicine in cardiovascular patients: from basic concepts to the clinical arena
- (2017) Sarah Costantino et al. EUROPEAN HEART JOURNAL
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis
- (2017) A. Gisterå et al. JOURNAL OF INTERNAL MEDICINE
- Interleukin-1 Beta as a Target for Atherosclerosis Therapy
- (2017) Peter Libby JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interleukin-6 “Trans-Signaling” and Ischemic Vascular Disease: The Important Role of Soluble gp130
- (2017) Mario Luca Morieri et al. MEDIATORS OF INFLAMMATION
- Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
- (2017) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
- (2017) José J. Fuster et al. SCIENCE
- Longitudinal and secular trends in total cholesterol levels and impact of lipid-lowering drug use among Norwegian women and men born in 1905–1977 in the population-based Tromsø Study 1979–2016
- (2017) Laila Arnesdatter Hopstock et al. BMJ Open
- Immune-mediated mechanisms of atherosclerosis and implications for the clinic
- (2016) Meritxell Nus et al. Expert Review of Clinical Immunology
- Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction
- (2016) Michelle L. O’Donoghue et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A randomized phase II study of Xilonix, a targeted therapy against interleukin 1α, for the prevention of superficial femoral artery restenosis after percutaneous revascularization
- (2016) Hosam El Sayed et al. JOURNAL OF VASCULAR SURGERY
- Mechanism of action of methotrexate in rheumatoid arthritis and the search for biomarkers
- (2016) Philip M. Brown et al. Nature Reviews Rheumatology
- Effects of the P‐Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT‐ACS Trial
- (2016) Barbara E. Stähli et al. Journal of the American Heart Association
- Twenty‐Five Year Secular Trends in Lipids and Modifiable Risk Factors in a Population‐Based Biracial Cohort: The Coronary Artery Risk Development in Young Adults (CARDIA) Study, 1985–2011
- (2016) Pamela J. Schreiner et al. Journal of the American Heart Association
- Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial
- (2015) Michelle L. O’Donoghue et al. AMERICAN HEART JOURNAL
- A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
- (2015) Joseph L. Goldstein et al. CELL
- Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer
- (2015) David S. Hong et al. INVESTIGATIONAL NEW DRUGS
- Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study
- (2015) Sotirios Tsimikas et al. LANCET
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Colchicine—Update on mechanisms of action and therapeutic uses
- (2015) Ying Ying Leung et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients With an Acute Coronary Syndrome
- (2015) Gonzalo J. Martínez et al. Journal of the American Heart Association
- Methotrexate Is a JAK/STAT Pathway Inhibitor
- (2015) Sally Thomas et al. PLoS One
- Therapeutic Potential of p38 MAP Kinase Inhibition in the Management of Cardiovascular Disease
- (2014) Marie Fisk et al. American Journal of Cardiovascular Drugs
- B Cells and Humoral Immunity in Atherosclerosis
- (2014) Dimitrios Tsiantoulas et al. CIRCULATION RESEARCH
- Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome
- (2014) Michelle L. O’Donoghue et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development
- (2014) A. S. Savchenko et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial
- (2014) L Kristin Newby et al. LANCET
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Thrombosis: tangled up in NETs
- (2013) K. Martinod et al. BLOOD
- The Interleukin-1 Family: Back to the Future
- (2013) Cecilia Garlanda et al. IMMUNITY
- Antioxidant Supplements to Prevent Mortality
- (2013) Goran Bjelakovic et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non–ST-Segment Elevation Myocardial Infarction
- (2013) Jean-Claude Tardif et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- IL-1 signaling in atherosclerosis: sibling rivalry
- (2013) Frederick J Sheedy et al. NATURE IMMUNOLOGY
- Fatty acid–induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis
- (2013) Stefan Freigang et al. NATURE IMMUNOLOGY
- A Randomized Trial of Colchicine for Acute Pericarditis
- (2013) Massimo Imazio et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meta-Regression Analyses, Meta-Analyses, and Trial Sequential Analyses of the Effects of Supplementation with Beta-Carotene, Vitamin A, and Vitamin E Singly or in Different Combinations on All-Cause Mortality: Do We Have Evidence for Lack of Harm?
- (2013) Goran Bjelakovic et al. PLoS One
- Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities
- (2013) I. Tabas et al. SCIENCE
- Inflammation in Atherosclerosis
- (2012) Peter Libby ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
- (2012) Stefan Rose-John International Journal of Biological Sciences
- Association of an Intensive Lifestyle Intervention With Remission of Type 2 Diabetes
- (2012) Edward W. Gregg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
- (2012) Stefan M. Nidorf et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
- (2012) LANCET
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
- (2012) LANCET
- Effects of p38 Mitogen-Activated Protein Kinase Inhibition on Vascular and Systemic Inflammation in Patients With Atherosclerosis
- (2012) Maysoon Elkhawad et al. JACC-Cardiovascular Imaging
- Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
- (2011) Paul M Ridker et al. AMERICAN HEART JOURNAL
- Transsignaling of Interleukin-6 Crucially Contributes to Atherosclerosis in Mice
- (2011) Harald Schuett et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
- (2011) Simon A. Jones et al. JOURNAL OF CLINICAL INVESTIGATION
- Lipoprotein-associated phospholipase A2 and atherosclerosis
- (2009) Robert L Wilensky et al. CURRENT OPINION IN LIPIDOLOGY
- Inflammation in Atherosclerosis
- (2009) Peter Libby et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)
- (2009) PAUL M. RIDKER JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The LDL modification hypothesis of atherogenesis: an update
- (2008) Daniel Steinberg JOURNAL OF LIPID RESEARCH
- Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial
- (2008) Jean-Claude Tardif et al. LANCET
- Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development
- (2008) Robert L Wilensky et al. NATURE MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now